MedPath

Efficacy and safety of hypoglycemic agents in nonalcoholic fatty liver disease with type 2 diabetes

Not Applicable
Recruiting
Conditions
nonalcoholic fatty liver disease with type 2 diabetes
Registration Number
JPRN-UMIN000045572
Lead Sponsor
ippon Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) daily alcohol consumption =>30 g for males and =>20 g for females 2) other chronic liver diseases, such as viral hepatitis B or C, autoimmune hepatitis, primary biliary cholangitis, Wilson disease, and hemochromatosis 3) pregnancy and lactation 4) Others judged unsuitable by researchers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath